☰

Brendan M. Giles, Ph.D. - Publications

Affiliations: 
2011 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Immunology, Virology Biology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Soloff AC, Bissel SJ, Junecko BF, Giles BM, Reinhart TA, Ross TM, Barratt-Boyes SM. Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates. The Journal of Infectious Diseases. 209: 2012-6. PMID 24403559 DOI: 10.1093/Infdis/Jiu009  0.628
2012 Giles BM, Crevar CJ, Carter DM, Bissel SJ, Schultz-Cherry S, Wiley CA, Ross TM. A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection. The Journal of Infectious Diseases. 205: 1562-70. PMID 22448011 DOI: 10.1093/Infdis/Jis232  0.806
2012 Giles BM, Ross TM. Computationally optimized antigens to overcome influenza viral diversity. Expert Review of Vaccines. 11: 267-9. PMID 22380818 DOI: 10.1586/Erv.12.3  0.62
2012 Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. Clinical and Vaccine Immunology : Cvi. 19: 128-39. PMID 22190399 DOI: 10.1128/Cvi.05533-11  0.793
2012 Giles BM, Bissel SJ, Craigo JK, Dealmeida DR, Wiley CA, Tumpey TM, Ross TM. Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice. Journal of Virology. 86: 1500-13. PMID 22130546 DOI: 10.1128/Jvi.06034-11  0.771
2012 Bissel SJ, Giles BM, Wang G, Olevian DC, Ross TM, Wiley CA. Acute murine H5N1 influenza A encephalitis. Brain Pathology (Zurich, Switzerland). 22: 150-8. PMID 21714828 DOI: 10.1111/J.1750-3639.2011.00514.X  0.627
2011 Schneider-Ohrum K, Giles BM, Weirback HK, Williams BL, DeAlmeida DR, Ross TM. Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice. Vaccine. 29: 9081-92. PMID 21963872 DOI: 10.1016/J.Vaccine.2011.09.051  0.77
2011 Giles BM, Ross TM. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine. 29: 3043-54. PMID 21320540 DOI: 10.1016/J.Vaccine.2011.01.100  0.781
2011 Ross TM, Bhardwaj N, Eugene HS, Giles BM, McBurney SP, Rossi SL, Schneider-Ohrum K, Tang XC. Virus-Like Particle Vaccines: Advantages and Challenges Development of Vaccines: From Discovery to Clinical Testing. 97-124. DOI: 10.1002/9781118023648.ch4  0.409
2010 Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, Zimmerman RK, Ostroff SM, Lee BY, Burke DS, Ross TM. Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. Plos One. 5: e11601. PMID 20644650 DOI: 10.1371/Journal.Pone.0011601  0.607
2010 Ross T, Zimmer S, Burke D, Crevar C, Carter D, Stark J, Giles B, Zimmerman R, Ostroff S, Lee B. Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. Plos Currents. 2: RRN1148. PMID 20191082 DOI: 10.1371/Currents.Rrn1148  0.626
Show low-probability matches.